Healthy Life

Has Healthy Life declared dividend?

No Dividend History Available

Who are the peers of the Healthy Life?

Healthy Life's peers include Hind. Unilever, ITC, Nestle India, and Britannia Inds., among others. Healthy Life shows excellent growth and returns, outperforming its peers, while management risk varies from excellent to below average across the group.

Peers: The peers of Healthy Life are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, B&A, Modern Dairies, James Warren Tea, Bengal Tea & Fab, and Sheetal Univer.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever and Godrej Consumer, and the rest. Below Average management risk is seen at Healthy Life, James Warren Tea, and Sheetal Univer., while Average management risk is found at Bengal Tea & Fab. Growth is Excellent for Healthy Life, while Average growth is noted at Nestle India, and the rest show Below Average growth, including Hind. Unilever, ITC, Britannia Inds., Godrej Consumer, B&A, and Bengal Tea & Fab. Capital Structure is Excellent for Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, while Good capital structure is seen at Healthy Life and B&A, and the rest do not qualify or are Below Average.<BR><BR>Return Snapshot: Healthy Life has a 1-year return of 215.29%, the highest among its peers, while B&A has the lowest at -24.67%. Healthy Life's return significantly exceeds all peers. Additionally, the six-month return is negative for Hind. Unilever, ITC, Godrej Consumer, B&A, and Bengal Tea & Fab.

What is the technical trend for Healthy Life?

As of May 29, 2025, Healthy Life's technical trend is mildly bullish, supported by daily moving averages and monthly Bollinger Bands, despite weekly indicators showing a mildly bearish stance.

As of 29 May 2025, the technical trend for Healthy Life has changed from mildly bearish to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and KST remain mildly bearish. The Bollinger Bands show a bullish signal on the monthly timeframe, contrasting with the weekly's mildly bearish indication. The Dow Theory reflects a mildly bullish trend on the monthly level but is mildly bearish on the weekly. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and the monthly Bollinger Bands.

Who are in the management team of Healthy Life?

As of March 2022, the management team of Healthy Life includes Divya Mojjada (Managing Director), Mohammed Sadiq (Non-Executive Director), Anil Kumar Vijay (Non-Executive & Independent Director), Pushpangathan Udayakumar (Non-Executive & Independent Director), and Shekhar Kapoor (Company Secretary). Each member contributes to the company's operations and governance.

As of March 2022, the management team of Healthy Life consists of the following individuals:<BR><BR>1. Divya Mojjada - Managing Director<BR>2. Mohammed Sadiq - Non Executive Director<BR>3. Anil Kumar Vijay - Non-Executive & Independent Director<BR>4. Pushpangathan Udayakumar - Non-Executive & Independent Director<BR>5. Shekhar Kapoor - Company Secretary<BR><BR>Each member plays a distinct role in overseeing the company's operations and governance.

What does Healthy Life do?

Healthy Life Agritec Ltd is a micro-cap company in the FMCG sector, originally incorporated in 2019 and renamed in 2022. It has a market cap of INR 177 Cr, with key metrics including a P/E ratio of 55.00 and a debt-equity ratio of 0.08.

Overview: <BR>Healthy Life Agritec Ltd operates in the Fast-Moving Consumer Goods (FMCG) sector and is categorized as a micro-cap company.<BR><BR>History: <BR>Healthy Life Agritec Ltd was originally incorporated in 2019 under the name "Tiff Care Industries Private Limited." The company changed its name to "Healthy Life Agritec Private Limited" in April 2020 and later converted to a Public Limited Company, adopting its current name on March 8, 2022. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 177 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 55.00 <BR>Industry P/E: 56 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.08 <BR>Return on Equity: 12.12% <BR>Price to Book: 6.59 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the top shareholders of the Healthy Life?

The top shareholders of Healthy Life include Cronosglobal Investments & Holdings Private Limited with 18.17%, and Kiran I Karnawat as the largest public shareholder at 2.91%. Individual investors hold 58.1% of the shares, with one Foreign Institutional Investor owning 0.4%, and there are no pledged promoter holdings or mutual funds.

The top shareholders of Healthy Life include Cronosglobal Investments & Holdings Private Limited, which holds the largest share at 18.17%. Additionally, Kiran I Karnawat is the highest public shareholder with a stake of 2.91%. The company has a significant portion of its shares held by individual investors, accounting for 58.1%. There is also one Foreign Institutional Investor (FII) that holds 0.4% of the shares. Notably, there are no pledged promoter holdings or mutual funds involved in the shareholding structure.

How big is Healthy Life?

As of 24th July, Healthy Life Agritec Ltd has a market capitalization of 166.00 Cr, classifying it as a Micro Cap company, with Shareholder's Funds of 26.91 Cr and Total Assets of 33.64 Cr; however, recent financial data for Net Sales and Net Profit is unavailable.

As of 24th July, <BR><BR>Market Cap: Healthy Life Agritec Ltd has a market capitalization of 166.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 26.91 Cr and Total Assets totaling 33.64 Cr.

When is the next results date for Healthy Life?

The next results date for Healthy Life is 14 November 2025.

The next results date for Healthy Life is scheduled for 14 November 2025.

How has been the historical performance of Healthy Life?

Healthy Life has shown significant growth in net sales, increasing from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25, with improved profitability reflected in rising operating profit and net income. However, cash flow from operating activities has declined, indicating challenges in cash management.

Answer:<BR>The historical performance of Healthy Life shows significant growth over the years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Healthy Life's net sales have increased from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25, reflecting a strong upward trend. The total operating income followed a similar trajectory, rising from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25. The company's total expenditure also grew, from 32.78 Cr in Mar'22 to 166.98 Cr in Mar'25, but the operating profit (PBDIT) improved from 1.18 Cr to 4.89 Cr during the same period, indicating enhanced operational efficiency. Profit before tax rose from 1.12 Cr in Mar'22 to 4.35 Cr in Mar'25, while profit after tax increased from 0.83 Cr to 3.26 Cr, showcasing a consistent improvement in profitability. The earnings per share (EPS) fluctuated, reaching 0.83 in Mar'25, down from 1.14 in Mar'24. On the balance sheet, total assets grew from 14.83 Cr in Mar'22 to 52.27 Cr in Mar'25, with total liabilities increasing from 14.83 Cr to 52.27 Cr as well. Cash flow from operating activities showed a negative trend, worsening from -8.00 Cr in Mar'22 to -5.00 Cr in Mar'25, while cash flow from financing activities improved significantly, rising from 10.00 Cr in Mar'22 to 8.00 Cr in Mar'25. Overall, Healthy Life has demonstrated robust growth in sales and profitability, despite challenges in cash flow management.

Is Healthy Life overvalued or undervalued?

As of November 18, 2025, Healthy Life is considered overvalued with a PE Ratio of 21.90 and an EV to EBITDA of 16.07, despite being lower than its peers Hindustan Unilever and Nestle India, and has experienced a significant year-to-date decline of 72.29% compared to the Sensex's 8.36% gain.

As of 18 November 2025, the valuation grade for Healthy Life has moved from very attractive to expensive. The company is currently considered overvalued. Key ratios include a PE Ratio of 21.90, an EV to EBITDA of 16.07, and a ROCE of 10.96%. <BR><BR>In comparison to its peers, Healthy Life's PE ratio is significantly lower than Hindustan Unilever's 53.39 and Nestle India's 81.48, both of which are categorized as very expensive. Despite this, Healthy Life's current valuation does not justify its price, especially given its recent stock performance, which has seen a drastic decline of 72.29% year-to-date, contrasting sharply with the Sensex's 8.36% gain in the same period.

Which are the latest news on Healthy Life?

Why is Healthy Life Agritec Ltd falling/rising?

As of 18-Jan, Healthy Life Agritec Ltd's stock price is currently at Rs 10.37, reflecting a short-term rise despite a significant decline over the past year. The stock is under pressure, trading lower than its moving averages and showing decreased investor participation.

As of 18-Jan, Healthy Life Agritec Ltd's stock price is rising, currently at Rs 10.37, reflecting an increase of Rs 0.13 or 1.27%. This rise is notable despite the stock's recent performance, which shows a decline of 4.60% over the past week and a significant drop of 14.08% over the past month. Year-to-date, the stock has decreased by 20.23%, and over the past year, it has fallen dramatically by 81.68%. <BR><BR>However, today's performance indicates that the stock has outperformed its sector by 1.07%, which may contribute to the positive movement in its price. Additionally, while the stock is trading lower than its moving averages across various time frames, the current price is only 3.57% away from its 52-week low, suggesting that it is still under pressure. The delivery volume has also decreased significantly, indicating falling investor participation, which could be a concern for future price stability. Overall, the current rise in price appears to be a short-term movement amidst a broader trend of decline.